LATEST ALERTS
This report offers a comprehensive overview of the current regulatory framework in place in Peru for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
US president Joe Biden has called for a scheduling review of cannabis. This report will examine the procedure, potential outcomes, and implications of this scheduling review.
This report provides a detailed overview of the regulatory framework in place in Uruguay for hemp, cannabis and CBD
This report examines which US states allow the sale of intoxicating hemp-derived cannabinoid (IHDC) products in licensed dispensaries and which states have dispensaries offering them – regardless of whether they are permitted – to demonstrate the states that effectively deter IHDC sales in dispensaries
Intoxicating hemp-derived cannabinoids (IHDC) have been major disruptors in the CBD and legal cannabis sectors in the US for some time now. This report details and analyses recent developments in their regulation
Mexico is set to become a major global market for cannabis and CBD, but its potential has been stymied by congressional inaction
This report offers a comprehensive overview of the current regulatory framework in Paraguay for hemp, CBD and cannabis (medical and recreational) as well as possible upcoming changes
The hemp and cannabis legal framework in Colombia has rapidly evolved over the last few months. This report offers an overview of the current regulatory regime
This regulatory report analyses the different approaches taken by states over what restrictions they impose on medical cannabis products that patients can buy
This report offers a comprehensive overview of the current regulatory framework for hemp, CBD and cannabis (medical and recreational) as well as possible upcoming changes
This report covers the regulatory framework for CBD, hemp and cannabis in Brazil
This report covers, state by state, the widely differing tax policies for medical cannabis in the US
Covers: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama. Overall, the region is restrictive on hemp and cannabis, with exceptions being Belize, Costa Rica and Panama
CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in over 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries
This report offers a comprehensive overview of California’s Assembly Bill (AB) 45, which is the culmination of years of legislative attempts to regulate hemp-derived products in the state
Some sellers of intoxicating cannabinoid products claim legality under the 2018 US Farm Bill. CBD-Intel believes that many hemp-derived cannabinoids do not violate federal controlled substance law
Chile has maintained a rather restrictive approach towards hemp and CBD. It has only recently allowed medicinal use of cannabis-based products, but there are still many legal grey areas as a consequence of the lack of regulation
This regulatory report examines which of the 36 US states that have legalised medical and/or recreational cannabis sales allow for home deliveries of cannabis products
This report covers, state by state, the question of whether each US state allows the sale of hemp-derived CBD vaping products and on what legal terms
This report examines US federal and all state law as it pertains to CBD in pet food
As CBD grows in popularity, its regulatory status remains poorly defined. In this report CBD-Intel reviews the regulatory framework of dietary supplements and where CBD fits, or would fit, within that framework
This report examines which US states that have legalised medical or recreational cannabis allow for the sale of hemp-derived CBD products in their dispensaries
Because US states can and do differ from federal law when it comes to controlled substances, it is important to analyse each state’s law on delta-8 THC. This report provides a state-by-state guide to delta-8 THC
Delta-8 THC has emerged as the hottest new cannabinoid in the US market. This report examines federal law on delta-8, notes trends that are happening at state level, and discusses what the future may hold
This report addresses the reasons why CBD and cannabis-related businesses in the US have trouble obtaining banking and payment processing services, what they can do, and what might be done to address the problem
This report examines the legal requirements and practical considerations when importing to and exporting from the largest CBD market in the world – the US
Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the rules
This report examines the current rules for US interstate transportation, covering documentation needed as well as individual courier rules
This report details the labelling requirements for CBD products of all US states that have enacted regulations and shows how manufacturers can create a versatile label to satisfy as many states’ regulations as possible
CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
